175 related articles for article (PubMed ID: 31309714)
1. Arterial and venous thrombosis by high platelet count and high hematocrit: 108 521 individuals from the Copenhagen General Population Study.
Warny M; Helby J; Birgens HS; Bojesen SE; Nordestgaard BG
J Thromb Haemost; 2019 Nov; 17(11):1898-1911. PubMed ID: 31309714
[TBL] [Abstract][Full Text] [Related]
2. Observationally and Genetically High YKL-40 and Risk of Venous Thromboembolism in the General Population: Cohort and Mendelian Randomization Studies.
Kjaergaard AD; Johansen JS; Bojesen SE; Nordestgaard BG
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):1030-6. PubMed ID: 26988593
[TBL] [Abstract][Full Text] [Related]
3. Increased rheumatoid factor and deep venous thrombosis: 2 cohort studies of 54628 individuals from the general population.
Meyer-Olesen CL; Nielsen SF; Nordestgaard BG
Clin Chem; 2015 Feb; 61(2):349-59. PubMed ID: 25278501
[TBL] [Abstract][Full Text] [Related]
4. Risk of future arterial cardiovascular events in patients with idiopathic venous thromboembolism.
Green D
Hematology Am Soc Hematol Educ Program; 2009; ():259-66. PubMed ID: 20008208
[TBL] [Abstract][Full Text] [Related]
5. High Incidence of Arterial and Venous Thrombosis in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
Kang A; Antonelou M; Wong NL; Tanna A; Arulkumaran N; Tam FWK; Pusey CD
J Rheumatol; 2019 Mar; 46(3):285-293. PubMed ID: 30385704
[TBL] [Abstract][Full Text] [Related]
6. Endogenous fibrinolysis-Relevance to clinical thrombosis risk assessment.
Kanji R; Kubica J; Navarese EP; Gorog DA
Eur J Clin Invest; 2021 Apr; 51(4):e13471. PubMed ID: 33296082
[TBL] [Abstract][Full Text] [Related]
7. Endogenous sex hormones and risk of venous thromboembolism in women and men.
Holmegard HN; Nordestgaard BG; Schnohr P; Tybjaerg-Hansen A; Benn M
J Thromb Haemost; 2014; 12(3):297-305. PubMed ID: 24329981
[TBL] [Abstract][Full Text] [Related]
8. Low Incidence of Symptomatic Thrombotic Events in Adult Patients Hospitalized with Coronavirus 19: A Retrospective Cohort Study.
Vallone MG; Vazquez C; Chuliber FA; Privitera V; Ferraris A; Cantarella RF; Indo MF; Sanchez Thomas DM; Peuchot VA; Vazquez FJ
Clin Appl Thromb Hemost; 2021; 27():10760296211051712. PubMed ID: 34714177
[TBL] [Abstract][Full Text] [Related]
9. ADP Platelet Hyperreactivity Predicts Cardiovascular Disease in the FHS (Framingham Heart Study).
Puurunen MK; Hwang SJ; Larson MG; Vasan RS; O'Donnell CJ; Tofler G; Johnson AD
J Am Heart Assoc; 2018 Mar; 7(5):. PubMed ID: 29502103
[TBL] [Abstract][Full Text] [Related]
10. ABO blood group influences risk of venous thromboembolism and myocardial infarction.
Pang H; Zong Z; Hao L; Cao Q
J Thromb Thrombolysis; 2020 Aug; 50(2):430-438. PubMed ID: 31820263
[TBL] [Abstract][Full Text] [Related]
11. Risk of arterial and venous thromboembolism in patients with atrial fibrillation or flutter: A nationwide population-based cohort study.
Sundbøll J; Hováth-Puhó E; Adelborg K; Ording A; Schmidt M; Bøtker HE; Sørensen HT
Int J Cardiol; 2017 Aug; 241():182-187. PubMed ID: 28473169
[TBL] [Abstract][Full Text] [Related]
12. ABO Blood Group and Risk of Thromboembolic and Arterial Disease: A Study of 1.5 Million Blood Donors.
Vasan SK; Rostgaard K; Majeed A; Ullum H; Titlestad KE; Pedersen OB; Erikstrup C; Nielsen KR; Melbye M; Nyrén O; Hjalgrim H; Edgren G
Circulation; 2016 Apr; 133(15):1449-57; discussion 1457. PubMed ID: 26939588
[TBL] [Abstract][Full Text] [Related]
13. [The clinical manifestations and thrombotic risk factors in primary antiphospholipid syndrome].
Zhao JL; Sun YD; Zhang Y; Xu D; Wang Q; Li MT; Zeng XF
Zhonghua Nei Ke Za Zhi; 2016 May; 55(5):386-91. PubMed ID: 27143190
[TBL] [Abstract][Full Text] [Related]
14. Mild antithrombin deficiency and risk of recurrent venous thromboembolism: results from the MEGA follow-up study.
Sokol J; Timp JF; le Cessie S; van Hylckama-Vlieg A; Rosendaal FR; Kubisz P; Cannegieter SC; Lijfering WM
J Thromb Haemost; 2018 Apr; 16(4):680-688. PubMed ID: 29377625
[TBL] [Abstract][Full Text] [Related]
15. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E
Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043
[TBL] [Abstract][Full Text] [Related]
16. Impact of incident venous thromboembolism on risk of arterial thrombotic diseases.
Lind C; Flinterman LE; Enga KF; Severinsen MT; Kristensen SR; Braekkan SK; Mathiesen EB; Njølstad I; Cannegieter SC; Overvad K; Hansen JB
Circulation; 2014 Feb; 129(8):855-63. PubMed ID: 24270266
[TBL] [Abstract][Full Text] [Related]
17. Venous and arterial thrombosis during oral contraceptive use: risks and risk factors.
Tanis BC; Rosendaal FR
Semin Vasc Med; 2003 Feb; 3(1):69-84. PubMed ID: 15199494
[TBL] [Abstract][Full Text] [Related]
18. Methionine-loading and random homocysteine tests have no added value in risk assessment for venous and arterial thrombosis.
Lijfering WM; Veeger NJ; Brouwer JL; van de Poel MH; van der Meer J
J Thromb Haemost; 2007 Mar; 5(3):614-6. PubMed ID: 17181828
[No Abstract] [Full Text] [Related]
19. Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients.
Lo Re V; Dutcher SK; Connolly JG; Perez-Vilar S; Carbonari DM; DeFor TA; Djibo DA; Harrington LB; Hou L; Hennessy S; Hubbard RA; Kempner ME; Kuntz JL; McMahill-Walraven CN; Mosley J; Pawloski PA; Petrone AB; Pishko AM; Driscoll MR; Steiner CA; Zhou Y; Cocoros NM
JAMA; 2022 Aug; 328(7):637-651. PubMed ID: 35972486
[TBL] [Abstract][Full Text] [Related]
20. Mean platelet volume is a risk factor for venous thromboembolism: the Tromsø Study, Tromsø, Norway.
Braekkan SK; Mathiesen EB; Njølstad I; Wilsgaard T; Størmer J; Hansen JB
J Thromb Haemost; 2010 Jan; 8(1):157-62. PubMed ID: 19496920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
